Clearmind Medicine (CMND) vs Mustang Bio (MBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Clearmind Medicine is the larger company by market cap ($3.3 million vs $3.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CMND | MBIO |
|---|---|---|
| Share price | $6.60 | $0.417 |
| Market cap | $3.35M | $3.16M |
| 1-day change | 0.00% | -7.37% |
| EPS (TTM) | $-461.20 | $-0.44 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3,840.00 | $1.85 |
| 52-week low | $5.25 | $0.4101 |
| Distance from 52-week high | -99.83% | -77.46% |
| Average volume | 70.35K | 29.24K |
| Shares outstanding | 507.40K | 6.73M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CMND vs MBIO FAQ
Which is bigger, Clearmind Medicine or Mustang Bio?
Clearmind Medicine (CMND) is larger, with a market capitalization of $3.35M compared with $3.16M for Mustang Bio (MBIO).
Are Clearmind Medicine and Mustang Bio in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.